Watchlist Price Alert

Royalty Pharma (RPRX)

NASDAQ: RPRX · Real-Time Price · USD

34.59

-0.51 (-1.45%)

At close: Jun 17, 2025, 1:23 PM

Royalty Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	929.03M	477.01M	1.71B	1.54B	1.01B	283.68M	1.92B	1.38B	1.67B
Short-Term Investments	58.2M	18.3M	717.04M	1.26B	983M	509.53M	461.82M	n/a	n/a
Long-Term Investments	16.39B	1.01B	14.23B	14.63B	13.27B	11.48B	8.67B	n/a	n/a
Other Long-Term Assets	16.23B	14.09B	15.13M	4.14M	28.6M	87.95M	19.11M	n/a	n/a
Receivables	26.96M	775.09M	727.92M	682.66M	626.36M	491.33M	660.45M	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	657.14M	n/a	19.2M	n/a	n/a
Other Current Assets	814.91M	3.8M	90.52M	6.63M	8.6M	92K	154.7M	1.57B	1.33B
Total Current Assets	1.8B	1.27B	2.55B	2.88B	2.7B	832.07M	2.61B	2.95B	3B
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	1.78M	14.5M	5.67M	28.67M	51.72M	75.65M	n/a	n/a
Total Long-Term Assets	16.42B	15.11B	14.26B	14.64B	13.32B	11.62B	8.76B	8.43B	7.48B
Total Assets	18.22B	16.38B	16.81B	17.52B	21.1B	12.45B	11.37B	11.37B	10.48B
Account Payables	13.37M	15.16M	7.91M	5.62M	10.78M	11.18M	4.48M	n/a	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	31.04M	n/a	n/a	n/a
Short-Term Debt	997.77M	n/a	997.51M	n/a	n/a	281.98M	281.44M	280.93M	172.68M
Other Current Liabilities	166.66M	94.53M	107.2M	107.93M	236.37M	40.26M	n/a	102.48M	124.63M
Total Current Liabilities	1.25B	161.38M	1.17B	171.25M	307.89M	333.42M	580.17M	383.41M	297.32M
Long-Term Debt	6.61B	6.14B	6.12B	7.1B	5.82B	5.96B	6.24B	6.52B	5.72B
Other Long-Term Liabilities	12.08M	900K	2.5M	n/a	n/a	18.9M	n/a	n/a	n/a
Total Long-Term Liabilities	6.63B	6.14B	6.12B	7.1B	5.82B	5.98B	6.24B	6.52B	5.72B
Total Liabilities	7.88B	6.3B	7.29B	7.27B	6.12B	6.31B	6.82B	6.9B	6.02B
Total Debt	7.61B	6.14B	7.12B	7.1B	5.82B	6.24B	6.52B	6.8B	5.9B
Common Stock	45K	45K	107K	106K	102K	3.28B	3.28B	n/a	n/a
Retained Earnings	2.85B	2.52B	1.96B	2.26B	1.92B	2.83B	1.22B	n/a	n/a
Comprehensive Income	n/a	n/a	63K	16.49M	34.4M	2.09M	-10.26M	n/a	n/a
Shareholders Equity	6.95B	6.53B	5.63B	5.78B	9.9B	6.11B	4.49B	4.46B	4.45B
Total Investments	245.16M	1.03B	533.94M	15.89B	14.25B	11.99B	605.42M	n/a	n/a